Santen sirolimus gets EC orphan drug status
Sirolimus is currently being evaluated in a Phase III study entitled ‘study assessing double-masked uveitis treatment’ (Sakura) to evaluate the safety and efficacy of different doses of sirolimus.
The Liverpool School of Tropical Medicine (LSTM) in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.